ArticlePloS one2025
Isolation, purification, and phenotypic characterization of virulent Klebsiella pneumoniae phages from environmental samples in Addis Ababa, Ethiopia: A synergistic approach combining spot assay and streak plating.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Genome sequences of four virulentMicrobiology resource announcements · 2026Article
- Protecting Newborns from Multidrug-Resistant Infections: The Emerging Role of Bacteriophages.Viruses · 2026Review
- Phage Therapy in Combating Multidrug-Resistant Gram-Negative Pathogens: A Scoping Review.Pharmaceuticals (Basel, Switzerland) · 2026Review
- Molecular characterization of virulence and antibiotic resistance genes in Klebsiella pneumoniae isolated from sputum samples at a tertiary hospital in Ethiopia.Scientific reports · 2026Article
- Isolation and characterization of lytic bacteriophages with therapeutic potential against multidrug resistant Klebsiella pneumoniae from Ethiopia.Scientific reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMultidrug-resistant (MDR) Klebsiella pneumoniae poses a significant global health threat, necessitating alternative therapies like bacteriophage treatment. Traditional phage isolation methods, such as plaque assays, are resource-intensive and thus limit large-scale screening. This study aimed to isolate and purify phages targeting MDR K. pneumoniae using a combined spot-streak plating method and to compare its efficiency with conventional techniques. MATERIALS AND
methodsA total of 62 environmental samples were screened against two MDR K. pneumoniae isolates using a combined approach: initial phage detection by spot assays followed by streak plate-based purification for isolating pure phage clones. Traditional plaque assays were also performed for comparison. Isolated phages were characterized by performing host range analysis against 45 bacterial isolates and determining their burst size. Additionally, their stability was assessed across various pH and temperature conditions, and single-step growth curve experiments were conducted.
resultsThe combined spot assay and streak plate purification method yielded 22 phages, whereas plaque assays isolated 17 phages. Eight phages with high titers and lytic activity were selected for further analysis. These phages exhibited broad host ranges, with two phages lysing up to 55.5% of tested isolates. Stability assays showed effective lytic activity between pH 5 and 9 and temperatures up to 60°C. Single-step growth curves revealed latent periods ranging from 15 to 40 minutes and burst sizes between 76 and 310 PFU per infected cell. The combined method reduced both the isolation time and resource requirements.
conclusionThe integration of spot assays with streak plate-based purification provides an efficient and less resource-intensive method for isolating diverse phages targeting MDR K. pneumoniae. The isolated phages demonstrate promising broad-spectrum lytic activity and physiological stability, supporting their potential use in phage therapy. RECOMMENDATION: Further genomic characterization is necessary to confirm the strictly lytic nature of these phages and to exclude the presence of undesirable genes. Subsequent studies should focus on in vivo efficacy testing and formulation optimization to facilitate clinical application.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.